$77.56
-10.28% past month
Notable price movement
Oct 23, 2026
$77.94-0.49%
Comparable listed companies in surgical and medical instruments fell 1.10% on average, with all 6 of 6 declining . DXCM's 0.49% decline came alongside that weakness, though it was smaller than the cohort average .
Oct 22, 2026
$78.32-2.42%
Comparable Surgical & Medical Instruments & Apparatus companies rose 1.52% on average, with 5 of 6 advancing . The company fell 2.42%, so its decline was not shared by the cohort . Volume was 3.2x its trailing 20-session average, and the session ranged from 77.11 to 80.49 .
Oct 21, 2026
$80.26-6.39%
DXCM fell 6.39% while comparable Surgical & Medical Instruments & Apparatus companies were roughly flat, moving -0.11% on average . The drop was therefore not shared by the cohort. Volume was 2.5x the trailing 20-session average .
Oct 20, 2026
$85.74-0.28%
Comparable surgical and medical instruments companies rose 1.46% on average, with all 6 of them rising . DXCM slipped 0.28% and did not take part in the group's gain .
Oct 19, 2026
$85.98-0.07%
Oct 16, 2026
$86.04-1.90%
Comparable surgical and medical instruments companies fell 0.93% on average, with 4 of 6 declining and 2 rising . DXCM's 1.90% drop was roughly twice the cohort's average decline, so it moved in the same direction as peers but by more .
Oct 15, 2026
$87.71+5.08%
Comparable surgical and medical instrument companies rose 2.15% on average, with all 6 higher . DexCom's 5.08% gain came alongside that sector strength and was more than double the average move . Seeking Alpha reported that DexCom gained as a NEJM publication boosted Medicare coverage hopes .
Closing prices for DXCM. Summaries describe past sessions only and are not advice, a forecast or a recommendation.
Recent news
Headlines are published by third parties and linked as reported. Amaltash does not endorse or verify them.
Prices and financial data are historical and provided for research only. Not investment advice.